ArticleMolecular therapy. Methods & clinical development2024

Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy.

Isabella Elias Yonezawa Ogusuku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.